Chemtura Expands MDI Prepolymers in Italy

US specialty chemicals company Chemtura is expanding capacity for Low Free (LF) MDI in Latina, Italy.  The expansion is due for completion by the end of 2016. The company said the extra output of its Adiprene LF MDI prepolymers will allow it to respond to growing customer demand as a replacement for polyurethane curing agent 4,4’methylenebis(2-chloroaniline), or MbOCA.

Under REACh legislation, EU companies will be prohibited from using MbOCA, a suspected carcinogen, beyond Nov. 22, 2017, unless they use 1 t/y or more and have secured authorization by May 22, 2016. Chemtura said the increase would also allow greater flexibility to balance production between the different LF prepolymer chemistries at its other facility in Gastonia, North Carolina, USA.

The company manufactures a broad range of LF prepolymers, including TDI, MDI, 1,4-phenylene diisocyanate (PPDI) and hexamethylene diisocyanate (HDI).

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read